TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novavax AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
45,675
|
73,932
|
141,170 |
| Financial expenses |
4,474
|
61,294
|
69,397 |
| Earnings before taxes |
22,659
|
17,565
|
46,565 |
| EBITDA |
12,281
|
20,167
|
48,255 |
| Total assets |
231,140
|
325,859
|
336,782 |
| Current assets |
11,959
|
18,521
|
237,002 |
| Current liabilities |
11,410
|
118,866
|
149,274 |
| Equity capital |
219,610
|
206,993
|
187,508 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
173
|
195
|
167 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
95.0%
|
63.5%
|
55.7% |
| Turnover per employee |
264
|
379
|
845 |
| Profit as a percentage of turnover |
49.6%
|
23.8%
|
33.0% |
| Return on assets (ROA) |
11.7%
|
24.2%
|
34.4% |
| Current ratio |
104.8%
|
15.6%
|
158.8% |
| Return on equity (ROE) |
10.3%
|
8.5%
|
24.8% |
| Change turnover |
-25,743
|
-67,650
|
53,027 |
| Change turnover % |
-36%
|
-48%
|
60% |
| Chg. No. of employees |
-22
|
28
|
167 |
| Chg. No. of employees % |
-11%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.